News

For some common medical conditions, timing is everything when it comes to taking medications. Now, a customizable capsule ...
Managing complex medication schedules could soon become as simple as taking a single capsule each day. Engineers at the ...
Linzagolix will only be available for patients whose previous medical or surgical treatments have been unsuccessful.
Life is hard enough, so why don't you convenience yourself with this portable charger and these handy blind-spot mirrors. View Entire Post › ...
The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, tremors and movement — for a longer period of time for patients who were also taking at least ...
Orforglipron, a new nonpeptide GLP-1 drug, may provide easier access for the treatment of Type 2 diabetes and obesity without injections. According to early clinical trial results shared on ...
The successful trial of a daily weight-loss pill has been hailed as a “landmark moment” in the fight against obesity, with Ireland’s leading expert in the field describing it as a “huge ...
David Ricks, Eli Lilly’s chief executive, called it a “convenient once-daily pill”. While meeting demand for existing drugs has been challenging, Mr Ricks said orforglipron could be quickly ...
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...
Ricks said in prepared remarks. "As a convenient once-daily pill, orforglipron may provide a new option and, if approved, could be readily manufactured and launched at scale for use by people ...
David A Ricks, Eli Lilly chair and chief executive, said: “As a convenient once-daily pill, orforglipron may provide a new option and, if approved, could be readily manufactured and launched at ...
Thursday’s results are the first from several studies of the daily pill, called orforglipron, expected this year from Lilly in patients with Type 2 diabetes and obesity. If the pill is approved ...